Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
  • Challenge: Making the integration of computational biology in cancer research routine

Oxford researchers are applying topological data analysis to deep phenotyping ‘omics and clinical data derived from patient receiving experimental therapies, for example, oesophageal cancer patients receiving a combination immunotherapy and chemo/radiotherapy. By interrogating multifaceted data from small clinical trials Oxford researchers are providing an agile and adaptive framework for identifying new biomarkers, stratifying patient response, and informing the development of improved treatment strategies at a patient-specific level.